TY - JOUR
T1 - Safety and outcomes of cryoablation for ventricular tachyarrhythmias
T2 - Results from a multicenter experience
AU - Di Biase, Luigi
AU - Al-Ahamad, Amin
AU - Santangeli, Pasquale
AU - Hsia, Henry H.
AU - Sanchez, Javier
AU - Bai, Rong
AU - Bailey, Shane
AU - Horton, Rodney
AU - Gallinghouse, G. Joseph
AU - Burkhardt, David J.
AU - Lakkireddy, Dhanunjay
AU - Yang, Yanfei
AU - Badhwar, Nitish
AU - Scheinman, Melvin
AU - Tung, Roderick
AU - Dello Russo, Antonio
AU - Pelargonio, Gemma
AU - Casella, Michela
AU - Tomassoni, Gery
AU - Shivkumar, Kalyanam
AU - Natale, Andrea
PY - 2011/7
Y1 - 2011/7
N2 - Background: Catheter ablation of ventricular arrhythmias (VAs) with cryoenergy has not been widely reported. Objective: The purpose of this study was to assess the feasibility and safety of cryoablation for VA. Methods: Cases where cryoablation of VA was attempted as the initial strategy or was considered to prevent potential damage to other structures such as the coronary arteries, phrenic nerve, and His bundle were collected. Thirty-three patients with either normal heart or structural heart disease undergoing VA ablation using cryoenergy at six different institutions were enrolled in the study. Epicardial access was obtained when appropriate. Results: Fifteen patients (7 men) underwent endocardial ablation, 13 (9 men) epicardial ablation (from the coronary sinus in 7), and 5 (2 men) aortic cusp ablation. Mean age was 54 ± 8 years, and ejection fraction was 45% ± 5%. In 15 (45%) patients, VAs were successfully ablated, whereas cryoablation was unsuccessful in the remaining 18 (55%) patients. Cryoablation was successful in all parahisian cases (100%). In three patients, epicardial cryoablation was successful after several failed attempts with open irrigated catheter. An aortic dissection occurred during catheter placement in the aortic cusp. At follow-up of 24 ± 5 months, all patients with acute success were free from clinical VA. Conclusion: Use of cryoenergy for ablation of VA has excellent success for arrhythmias near the His bundle; however, success rates at other sites appear less favorable. Cryoablation may be considered as an alternative approach for reducing complications during ablation of VAs originating from sites close to other relevant cardiac structures (conduction system, coronary arteries, phrenic nerve) and, in rare cases, could be used epicardially when radiofrequency energy applications have failed.
AB - Background: Catheter ablation of ventricular arrhythmias (VAs) with cryoenergy has not been widely reported. Objective: The purpose of this study was to assess the feasibility and safety of cryoablation for VA. Methods: Cases where cryoablation of VA was attempted as the initial strategy or was considered to prevent potential damage to other structures such as the coronary arteries, phrenic nerve, and His bundle were collected. Thirty-three patients with either normal heart or structural heart disease undergoing VA ablation using cryoenergy at six different institutions were enrolled in the study. Epicardial access was obtained when appropriate. Results: Fifteen patients (7 men) underwent endocardial ablation, 13 (9 men) epicardial ablation (from the coronary sinus in 7), and 5 (2 men) aortic cusp ablation. Mean age was 54 ± 8 years, and ejection fraction was 45% ± 5%. In 15 (45%) patients, VAs were successfully ablated, whereas cryoablation was unsuccessful in the remaining 18 (55%) patients. Cryoablation was successful in all parahisian cases (100%). In three patients, epicardial cryoablation was successful after several failed attempts with open irrigated catheter. An aortic dissection occurred during catheter placement in the aortic cusp. At follow-up of 24 ± 5 months, all patients with acute success were free from clinical VA. Conclusion: Use of cryoenergy for ablation of VA has excellent success for arrhythmias near the His bundle; however, success rates at other sites appear less favorable. Cryoablation may be considered as an alternative approach for reducing complications during ablation of VAs originating from sites close to other relevant cardiac structures (conduction system, coronary arteries, phrenic nerve) and, in rare cases, could be used epicardially when radiofrequency energy applications have failed.
KW - Cardiomyopathy
KW - Cryocatheter ablation
KW - Normal heart
KW - Ventricular tachycardia
UR - http://www.scopus.com/inward/record.url?scp=79959941979&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959941979&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2011.02.038
DO - 10.1016/j.hrthm.2011.02.038
M3 - Article
C2 - 21376835
AN - SCOPUS:79959941979
SN - 1547-5271
VL - 8
SP - 968
EP - 974
JO - Heart Rhythm
JF - Heart Rhythm
IS - 7
ER -